Financials of Dr Reddys Laboratories Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Dr Reddys Laboratories Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6,3156,7586,9037,2377,1147,6968,0388,3818,5288,5728,8288,7537,546
Expenses +4,7814,6964,8945,2145,2835,5665,9626,1086,5306,3986,8186,8667,164
Operating Profit1,5342,0622,0082,0231,8312,1302,0762,2731,9982,1742,0101,888382
OPM %24%31%29%28%26%28%26%27%23%25%23%22%5%
Other Income +146178319219201193314154528290330271480
Interest353735395960768266839194106
Depreciation316353376374368381397471455476505521557
Profit before tax1,3291,8501,9171,8291,6051,8831,9171,8742,0051,9051,7451,543200
Tax %28%24%23%24%18%26%30%25%21%26%23%23%-11%
Net Profit +9601,4051,4821,3811,3101,3921,3421,4041,5871,4101,3371,190221
EPS in Rs11.5316.8717.7716.5615.7016.6915.0516.9419.0916.9916.1414.502.65

Financials of Dr Reddys Laboratories Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +15,02315,56814,19614,28115,44817,51719,04821,54524,67028,01132,64433,700
Expenses +11,51511,98311,72411,93012,27015,04015,17317,77818,20020,07824,09727,247
Operating Profit3,5083,5852,4722,3513,1782,4773,8743,7686,4707,9338,5476,454
OPM %23%23%17%16%21%14%20%17%26%28%26%19%
Other Income +2602951721553816703355559719091,1191,372
Interest10883637989989796143171283374
Depreciation7609391,0271,0771,1351,1631,2291,1651,2501,4701,7042,059
Profit before tax2,9002,8591,5541,3502,3361,8862,8843,0616,0487,2017,6805,393
Tax %19%26%19%32%17%-7%32%29%25%23%25%23%
Net Profit +2,3362,1311,2929471,9502,0261,9522,1824,5075,5785,7254,158
EPS in Rs27.4324.9815.5911.4123.4924.3823.4726.2354.1466.8767.7750.27
Dividend Payout %15%16%26%35%17%21%21%23%15%12%12%16%

Financials of Dr Reddys Laboratories Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital858583838383838383838384
Reserves9,76812,48412,17912,48913,94115,51617,55819,12923,20328,17133,46637,808
Borrowings +4,3143,3524,9185,0713,8382,2103,0313,3841,3472,0024,6777,734
Other Liabilities +4,2904,4084,4744,7064,5575,4145,9157,1497,5768,5239,79712,498
Total Liabilities18,45720,33021,65422,34922,41823,22326,58829,74632,20938,78048,02358,123
Fixed Assets +5,3776,5636,9316,9687,1916,8508,2068,1229,21910,42618,22622,063
CWIP5297723,3243,4702,9341,5351,5651,2931,0301,4192,4661,460
Investments2,2483,8332,1102,2982,5872,6782,2122,6164,9864,9304,0515,285
Other Assets +10,3039,1629,2909,6129,70712,16014,60517,71516,97422,00423,28029,315
Total Assets18,45720,33021,65422,34922,41823,22326,58829,74632,20938,78048,02358,123

Financials of Dr Reddys Laboratories Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +2,5243,2632,1441,8032,8702,9843,5702,8115,8884,5434,6435,674
Cash from Investing Activity +-2,370-1,610-1,890-1,483-769-495-2,255-2,565-4,109-4,034-5,785-6,549
Cash from Financing Activity +-433-1,700-369-444-2,133-2,516-30-242-2,686-3761,891829
Net Cash Flow-280-47-114-124-31-271,2863-907133749-47
Free Cash Flow1,0092,0659267132,2482,4122,3231,2384,0091,9081,3272,004
CFO/OP88%111%110%88%106%149%107%94%108%83%78%109%

Financials of Dr Reddys Laboratories Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days10097981049410595113107105101110
Inventory Days248248282263273230273250232283260228
Days Payable84881041211111001091111081169791
Cash Conversion Cycle264257275246256235259252231271264247
Working Capital Days2634-1439655957618411869109
ROCE %22%19%9%8%13%11%16%14%27%27%23%14%